#PVUSA | #PVAMERICAS
Pharmacovigilance USA 2021
25-26 February 2021
Speaker Proposals are Invited.
Welcome to America's Leading Pharmacovigilance Conference & Exhibition
Email your abstracts proposals to email@example.com
Pharmacovigilance USA 2021 Congress will give its participants an opportunity and a platform to share experiences with the likeminded individuals in the field. The conference will also provide an insight into the complexities and challenges impacting public safety and risk management, focusing mainly on drugs, biologics and medical devices and the future of PV in the globalization era.
The conference will bring together industry experts and regulators to discuss the new updates in US legislation, operational challenges of implication of these changes, experience of implementing global risk management plans, the best and effective way forward, impact of IT and social media on PV and harmonization of different regulatory bodies.
Explore the impact of PV legislation changes and updates on industries and the best practices
Assuring Compliance and its monitoring
Preparing for PV audit and inspections and the role of QPPV
Risk management plans, strategies and new risk- benefit analysis tools to improve REMS reporting
Implementing risk management and safety surveillance methodologies for medical devices
New approaches for risk minimization and communication
Determining steps and strategies for more transparency and involvement of patients
Discussing the how IT and Social media effect Pharmacovigilance and Adverse events reporting
Discuss and review the use of databases and emerging tools for generation and detection of safety signals
Importance of outsourcing and its effectiveness
Harmonization of regulatory framework- developed and emerging markets
Why Should You Attend
Pharma/BioTech companies are always faced with the challenge to improve quality of the safety data with the ever-increasing quantity of the data. The companies are also left with the challenge to manage the dynamic regulatory requirements. There are still many complexities that the industries and the regulatory authorities have to tackle. With more communication and networking you can expand your knowledge on the key complications currently experienced by various industries and departments and design new strategies to overcome the same.
Who Should Attend
VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Research Scholars and professionals with intermediate to advance knowledge and experience in the following
Drug Research & Development
Information and Clinical Data Management
Medical product safety assessment
Clinical research & safety
Sales and Marketing
*Graviton International Terms and Conditions (T&C) applicable.
Have an issue with this listing? Report it here.